From the Department of Ophthalmology (Vrijman, van der Meulen, Mourits, Lapid-Gortzak), Academic Medical Center, University of Amsterdam, Amsterdam, and Retina Total Eye Care (van der Meulen, van der Linden, Lapid-Gortzak), Driebergen, the Netherlands.
From the Department of Ophthalmology (Vrijman, van der Meulen, Mourits, Lapid-Gortzak), Academic Medical Center, University of Amsterdam, Amsterdam, and Retina Total Eye Care (van der Meulen, van der Linden, Lapid-Gortzak), Driebergen, the Netherlands.
J Cataract Refract Surg. 2018 Apr;44(4):466-470. doi: 10.1016/j.jcrs.2018.01.030. Epub 2018 Apr 22.
To describe the outcomes in terms of the refraction and visual acuity of multifocal intraocular lens (IOL) implantation in patients with previous hyperopic corneal refractive laser surgery.
Academic Medical Center, University of Amsterdam, Amsterdam, and Retina Total Eye Care, Driebergen, the Netherlands.
Retrospective case series.
Results were analyzed 3 months after implantation of a multifocal IOL (Acrysof Restor SN6AD1) in patients after previous corneal refractive laser surgery for hyperopia. The primary outcome measures were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and refraction. The secondary outcome measures were the number of laser enhancements and posterior capsule opacification (PCO) rates.
Forty eyes of 40 patients were included. Sixteen eyes (40.0%) had lens extraction because of cataract, and 24 eyes (60.0%) had refractive lens exchange. The mean postoperative UDVA was 0.16 logarithm of the minimum angle of resolution (logMAR) ± 0.18 (SD), and the mean postoperative CDVA was 0.01 ± 0.08 logMAR. The mean postoperative spherical equivalent was 0.04 ± 0.92 diopter (D). Twenty-five eyes (62.5%) were within ±0.50 D of emmetropia, and 35 eyes (87.5%) were within ±1.0 D of emmetropia. Nine eyes (22.5%) had a laser enhancement because of a residual refraction error. Eleven eyes (27.5%) had a neodymium:YAG laser capsulotomy because of PCO.
In general, multifocal IOL implantation after corneal refractive laser surgery for hyperopia resulted in good visual acuity and refraction. The magnitude of previous hyperopia did not influence the refractive predictability.
描述在既往远视角膜屈光激光手术后植入多焦点人工晶状体(IOL)的患者的屈光度和视力结果。
阿姆斯特丹大学学术医学中心和荷兰德雷伯根的 Retina Total Eye Care。
回顾性病例系列。
在既往因远视行角膜屈光激光手术的患者中,分析植入多焦点 IOL(Acrysof Restor SN6AD1)后 3 个月的结果。主要观察指标为未矫正远视力(UDVA)、矫正远视力(CDVA)和屈光度。次要观察指标为激光增强次数和后囊混浊(PCO)发生率。
共纳入 40 例 40 只眼。16 只眼(40.0%)因白内障行晶状体摘除,24 只眼(60.0%)行屈光性晶状体置换。术后平均 UDVA 为 0.16 对数最小分辨角对数(logMAR)±0.18(SD),平均术后 CDVA 为 0.01±0.08 logMAR。术后平均等效球镜为 0.04±0.92 屈光度(D)。25 只眼(62.5%)在±0.50 D 以内达到正视,35 只眼(87.5%)在±1.0 D 以内达到正视。9 只眼(22.5%)因残余屈光误差行激光增强,11 只眼(27.5%)因 PCO 行钕:YAG 激光后囊切开术。
一般来说,在既往远视角膜屈光激光手术后植入多焦点 IOL 可获得良好的视力和屈光度。术前远视的程度并不影响预测的准确性。